Core Viewpoint - Catalyst Pharmaceuticals, Inc. is set to release its third quarter 2025 financial results on November 5, 2025, and will host a conference call and webcast on November 6, 2025, to discuss these results and provide a business update [1][2]. Group 1: Financial Results Announcement - The company will announce its third quarter 2025 financial results after market close on November 5, 2025 [1]. - A conference call and webcast will take place on November 6, 2025, at 8:30 AM ET to discuss the financial results [2]. Group 2: Conference Call & Webcast Details - The conference call can be accessed via US/Canada dial-in number 877-407-8912 and international dial-in number 201-689-8059 [3]. - The webcast will be available on the company's website and a replay will be accessible for at least 30 days following the event [3]. Group 3: Company Overview - Catalyst Pharmaceuticals is focused on developing and commercializing novel medicines for patients with rare diseases [4]. - The company has been recognized on the Forbes 2025 list as one of America's Most Successful Mid-Cap Companies and on the 2024 Deloitte Technology Fast 500™ list as one of North America's Fastest-Growing Companies [4].
Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025